3 Reasons Investors Love Insulet (PODD) Over the past six months, Insulet has been a great trade. While the S&P 500 was flat, the stock price has climbed by 14.6% to $265.87 per share. This was ...

Insulet experienced a 12% decline in its stock price over the past week following its earnings announcement and corporate guidance. The company reported strong year-over-year sales growth, however ...

Insulet experienced a 5% increase in share price over the past week, a period marked by significant financial advancements and product developments. The company's successful closure of $450 ...

Insulet Corporation PODD has witnessed strong momentum in the past year. Shares of the company have risen 62.9% compared with 9.9% growth of the industry during the same time frame. The S&P 500 ...

The Wright Museum and Bank of America expand Black history access with free programs, cultural preservation, and deep community engagement.

Scott Wright has undergone surgery on his knee after suffering a season-ending injury in Birmingham City’s draw at Reading last month. The winger’s right knee buckled underneath him at the Select Car ...

Just shy of two years after a C-suite reorganization at Insulet, Mark Field has left his position as the inaugural chief technology officer at the Acton medical device manufacturer. Field ...

It might be of some concern to shareholders to see the Insulet Corporation (NASDAQ:PODD) share price down 11% in the last month. But the silver lining is the stock is up over five years.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its revolutionary Omnipod 5 ...